BEAM vs MTB · rev $63.5M vs P/E 12, $30.99B cap
Beam Therapeutics Inc (BEAM) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
MTB does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the BEAM and MTB stock pages for the full models.
Not investment advice.